The CARDIOPROTECT Trial | MicrobiomeTrials← Back to trialsNCT07654426
The CARDIOPROTECT Trial
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-08-31Est. Completion: 2030-12-31
Enrollment target: 60 participants Locations- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
B-cell Acute Lymphoblastic LeukemiaDiffuse Large B-cell LymphomaBurkitt LymphomaNeuroblastomaEwing Sarcoma
Substudy 01A is part of a platform study. The purpose of this study is to assess the efficacy and safety of zilovertamab…
Los Angeles, United StatesEst. completion Mar 31, 2029
Lymphoma, Non-HodgkinLymphoma, FollicularLymphoma, Large B-Cell, Diffuse
Researchers are looking for new ways to treat 2 types of non-Hodgkin lymphoma (NHL) called follicular lymphoma (FL) and …
Denver, United StatesEst. completion Jul 1, 2030